AI News July 2, 2026: Anthropic's big comeback, Meta's cloud ambitions, and fair use legal battles
📅 July 2, 2026 · 5 min read · GuideGuru News Desk
Today in AI news, **Anthropic** is back in the spotlight with eye-watering revenue growth and the lifting of a crucial ban, while **Meta** makes a big move into the AI cloud business. We also explore the ongoing legal debates around **AI training data** and a bold proposal from **OpenAI** to share its wealth with the public.
⚡ Today at a glance
- **Anthropic** reports explosive revenue growth and sees its most powerful Claude models unbanned by the US government.
- **Meta** is planning to launch a new cloud infrastructure business, selling AI computing power and model access to compete with tech giants.
- **US courts are split** on whether using copyrighted material to train AI models constitutes "fair use," setting critical legal precedents.
- **OpenAI** CEO Sam Altman has reportedly proposed donating 5% of the company's equity to a US sovereign wealth fund.
- **Mankind Pharma** has partnered with Denovo Sciences to accelerate drug discovery using AI, aiming to cut early research timelines.
📈 Anthropic's Explosive Growth and Unbanned Models Reshape the AI Landscape
Business
Anthropic's revenue soars as its powerful AI models are cleared for wider use.
AI leader **Anthropic** is making waves with reports of explosive revenue growth, jumping from an estimated **$1 billion to $10 billion ARR**, and now hitting a staggering **$50 billion annual run-rate**, thanks to popular models like Opus 4.5 and Fabl. This financial success comes alongside a significant regulatory development: the **US government has lifted an 18-day export control order** on Anthropic’s most powerful Claude AI models, including the latest **Claude Fable 5**, following a resolution of cybersecurity concerns.
The unbanning means developers and businesses can once again access these cutting-edge models without restriction, likely further fueling Anthropic's growth and competitive position against rivals like OpenAI. This rapid expansion highlights the intense demand for advanced AI capabilities and the quick pace at which regulatory bodies are trying to keep up with the technology's implications.
What it means for you: More advanced AI models from Anthropic will be widely available, potentially leading to smarter chatbots and AI tools in various applications. Keep an eye out for new features powered by Claude.
☁️ Meta Plans New Cloud Business to Challenge Big Tech in AI Computing
New Launch
Meta is entering the AI cloud market, aiming to sell computing power and model access to rivals.
**Meta** is reportedly gearing up to launch a new cloud infrastructure business, positioning itself to sell **AI computing power and access to its large language models (LLMs)**. This strategic move would place Meta in direct competition with established cloud leaders such as **Amazon Web Services (AWS)**, **Microsoft Azure**, and **Google Cloud**, which already offer extensive AI services and infrastructure to other businesses.
By leveraging its massive investment in AI research and hardware, Meta aims to diversify its revenue streams beyond advertising and social media. This new venture could create more options for companies seeking AI infrastructure, potentially driving down costs and accelerating innovation across the industry as competition heats up among tech giants.
What it means for you: More competition in AI computing could lead to more affordable and accessible AI tools and services. Businesses might find new options for powering their AI projects, and we could see faster innovation.
⚖️ Courts Split on Whether AI Training Is "Fair Use"
Regulation
Legal battles over AI training data are creating conflicting rulings, impacting future development.
A crucial legal debate is intensifying as US courts deliver **mixed rulings on whether the use of copyrighted material to train AI models qualifies as "fair use."** This first wave of AI regulation focuses heavily on transparency, with laws like California’s **Training Data Transparency Act** (effective Jan. 1) requiring developers to disclose their data sources. However, the core question of whether scraping public data without permission is legal remains unresolved, with judges currently disagreeing.
The outcome of these cases will have profound implications for the entire AI industry, dictating how models can be trained and how content creators are compensated. Clear legal precedents are essential for both AI developers, who need certainty about their data acquisition practices, and artists/writers, who seek protection for their intellectual property in the age of generative AI.
What it means for you: The future of how AI learns and what it can generate is in the hands of the courts. These decisions could impact the quality, cost, and availability of AI tools, and how your own creative work is protected online.
💰 OpenAI Proposes Donating 5% Equity to US Sovereign Wealth Fund
Business
Sam Altman suggests a novel way to share AI's financial gains with the public.
**OpenAI CEO Sam Altman** has reportedly put forward a groundbreaking proposal: donating **5% of the company’s equity to a US sovereign wealth fund**. This bold move revives discussions about how the public can directly benefit from the immense financial gains generated by the booming artificial intelligence sector. Such a fund could potentially invest in public services, infrastructure, or other initiatives, ensuring that the wealth created by AI doesn't solely remain with a few private entities.
This proposal reflects a growing sentiment within the AI community about the societal responsibility of leading AI companies. It could set a precedent for how future AI-driven profits are distributed, potentially leading to more equitable economic growth as AI continues to transform industries and create vast new value.
What it means for you: This is a big idea that could mean some of AI's profits go back to public benefit. While not a direct impact on your daily AI use, it could influence future government spending or public projects funded by AI success.
🔬 Mankind Pharma and Denovo Sciences Partner for AI-Led Drug Discovery
Business
AI is being deployed to drastically speed up the development of new medicines.
**Mankind Pharma**, a major pharmaceutical company, has announced a partnership with **Denovo Sciences** to accelerate drug discovery through the power of artificial intelligence. This collaboration aims to significantly **cut down early research timelines**, enhance the quality of potential drug candidates, and ensure that only the most promising compounds move forward in development. By using AI algorithms, researchers can analyze vast datasets of biological and chemical information much faster than traditional methods, identifying patterns and predicting molecular interactions.
The application of AI in drug discovery is a game-changer for the healthcare industry. It promises to bring new, life-saving medications to market faster and more efficiently, reducing the time and immense costs typically associated with developing new drugs. This partnership represents a growing trend of leveraging AI for complex scientific challenges.
What it means for you: AI could help bring new medicines to market faster and potentially at a lower cost. This means quicker access to treatments for various diseases and more efficient healthcare innovation.